Successful treatment of an aggressive recurrent post-menopausal endometriosis with an aromatase inhibitor.

[1]  S. Altunyurt,et al.  Regression of endometrial explants in rats treated with the cyclooxygenase-2 inhibitor rofecoxib. , 2004, Fertility and sterility.

[2]  D. Olive,et al.  New medical treatments for endometriosis. , 2004, Best practice & research. Clinical obstetrics & gynaecology.

[3]  F. Petraglia,et al.  Treatment of severe recurrent endometriosis with an aromatase inhibitor in a young ovariectomised woman , 2004, BJOG : an international journal of obstetrics and gynaecology.

[4]  A. Goumenou,et al.  Endometriosis arising during estrogen and testosterone treatment 17 years after abdominal hysterectomy: a case report. , 2003, Maturitas.

[5]  A. Rafii,et al.  Sigmoid endometriosis in a postmenopausal woman. , 2002, American journal of obstetrics and gynecology.

[6]  S. Bulun,et al.  Mechanisms of excessive estrogen formation in endometriosis. , 2002, Journal of reproductive immunology.

[7]  H. Sasano,et al.  Treatment of severe postmenopausal endometriosis with an aromatase inhibitor. , 1998, Fertility and sterility.

[8]  S. Soysal,et al.  The effects of post-surgical administration of goserelin plus anastrozole compared to goserelin alone in patients with severe endometriosis: a prospective randomized trial. , 2004, Human reproduction.

[9]  H. Tournaye,et al.  Clomiphene citrate versus letrozole for ovarian stimulation: a pilot study. , 2003, Reproductive biomedicine online.

[10]  T. Child,et al.  Endometriosis: aetiology, pathogenesis and treatment. , 2001, Drugs.

[11]  S. Bulun,et al.  Aromatase expression in endometriosis. , 1996, The Journal of clinical endocrinology and metabolism.